Drugs / Artemether-Lumefantrine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01065116 | Mar → Nov 2010 | malaria | Malaria Consortium, Uganda | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Artemether-Lumefantrine | “Effectiveness and Treatment Adherence to Artemether/Lumefantrine Pre-packs Versus Blister Packs in the Treatment of Uncomplicated Malaria in Uganda” NCT01065116 ↗1“Uganda adopted Artemether-Lumefantrine (AL) as first line treatment for uncomplicated malaria.” NCT01065116 ↗ |